<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H59DDC24FE8854D8F895FF335F553983E" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 7377 IH: Modernizing Therapeutic Equivalence Rating Determination Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-04-04</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7377</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220404">April 4, 2022</action-date><action-desc><sponsor name-id="C001114">Mr. Curtis</sponsor> (for himself and <cosponsor name-id="C001119">Ms. Craig</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to modernize therapeutic equivalence rating determinations.</official-title></form><legis-body id="H8C70C7CF44B64FC781C9DD2C2A7999C0" style="OLC"><section id="H15654E2EEF074309B1350DC41AB47E29" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Modernizing Therapeutic Equivalence Rating Determination Act</short-title></quote>.</text></section><section id="H5F429180A8994CCE9C472796160B9FBF"><enum>2.</enum><header>Therapeutic equivalence determinations</header><text display-inline="no-display-inline">Section 505(j)(7)(A) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355(j)(7)(A)</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HF8FF6D759E634A94ADA68E1A6312FFA4"><clause id="H3277D7608B3C422883EA6F641BA57D33" indent="up3"><enum>(v)</enum><subclause commented="no" display-inline="yes-display-inline" id="HEE1547F9D4F84F858A28D1D4CF311BF4"><enum>(I)</enum><text>The Secretary shall make a determination under clause (i)(III)—</text><item indent="up1" id="H27699BBC6F3746D58FA11279800977E2"><enum>(aa)</enum><text>with respect to an application submitted under this subsection, at the time of approval of such application or not later than 30 days after the date of such approval; or</text></item><item indent="up1" id="H83B87A1D9DFB44E7B10FABD5B01EF1D0"><enum>(bb)</enum><text>with respect to an application submitted under subsection (b)(2), at the time of approval of such application or not later than 30 days after the date of such approval, provided that the sponsor requests such a determination in the original application, in a form prescribed by the Secretary. </text></item></subclause><subclause indent="up1" id="H798B940E98E645E6A3E762B6C13E81B5"><enum>(II)</enum><text>When the Secretary makes a determination under clause (i)(III), the Secretary shall, in revisions made to the list pursuant to clause (ii), include such information for such drug.</text></subclause><subclause indent="up1" id="HD9BB473C1E914A9EA72EAEEE21784D91"><enum>(III)</enum><text>When the Secretary makes a determination under clause (i)(III) with respect to a drug, the Secretary shall, at the same time, make such a determination with respect to any other drug—</text><item id="H2529CADEF4C2487A8888AFCC6D1693A2"><enum>(aa)</enum><text>whose application under subsection (b)(2) was approved; </text></item><item id="H2EAB0BD9FEAC4F01A3A73C202E016E39"><enum>(bb)</enum><text>which references the same listed drug as the application for the first drug for which such determination is made; and</text></item><item id="H20B5C5FDAE6D4B15973C8B7825123EAC"><enum>(cc)</enum><text>for which there is a citizen petition pending requesting that the Secretary make a determination under clause (i)(III).</text></item></subclause></clause><after-quoted-block>.</after-quoted-block></quoted-block></section></legis-body></bill> 

